SCHEMBL5692346

SCHEMBL5692346

CCCCCCS(=O)(=O)c1nc(C(=O)OC(C)(C)C)cc(-c2cc(OC)c(OC)c(OC)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SDHB P21912 2/20 0.41
▸ TP53 P04637 7/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ TLR8 Q9NR97 1/20 0.38
▸ ECE1 P42892 1/20 0.38
▸ KMT2A Q03164 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ HTR1A P08908 2/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ HTR7 P34969 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ STAT3 P40763 2/20 0.36
▸ STAT1 P42224 2/20 0.36
▸ HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5690844 0.81 TLR8 (0.38) SMN1; SMN2TLR8ECE1KMT2ALMNA
SCHEMBL5691603 0.80 TLR8 (0.39) SMN1; SMN2TLR8ECE1KMT2ALMNA
SCHEMBL5363392 0.71 THRB (0.37) SDHBHPGDKDM4E
SCHEMBL5691492 0.69 ADORA3 (0.41) SMN1; SMN2TLR8ECE1KMT2ALMNA
SCHEMBL5691615 0.68 ECE1 (0.38) SMN1; SMN2TLR8ECE1KMT2AHTR1A
SCHEMBL5691459 0.67 ECE1 (0.49) SMN1; SMN2TLR8ECE1LMNANPSR1
SCHEMBL5692010 0.65 ECE1 (0.38) SMN1; SMN2TLR8ECE1KMT2ALMNA
SCHEMBL5690836 0.65 ECE1 (0.50) SMN1; SMN2TLR8ECE1KMT2ALMNA
SCHEMBL13996908 0.61 MEN1 (0.42) KMT2AMAPTTDP1
SCHEMBL5367572 0.61 KDM4E (0.40) SDHBTP53SMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644338-A1 2, 4, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES Aponetics AG (CH) 2006-04-12 — — EP disclosed
WO-2004087679-A1 2, 4, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES APONETICS AG (CH) 2004-10-14 — — WO disclosed
Send feedback